Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess performance of medtronic¿s protégé rx self-expanding peripheral stent system and medtronic¿s protégé gps self-expanding peripheral stent system.Survey results are received for a vascular surgeon practicing in germany.The physician has been using the protégé rx self-expanding peripheral stent system since 2010 and the protégé gps self-expanding peripheral stent system since 2013 for the treatment of lesions that appear to be at high risk for restenosis following pta in the subclavian arteries.Within the last 12 months, the protégé rx self-expanding peripheral stent system was used for the treatment of lesions that appear to be at high risk for restenosis following pta in the subclavian arteries in 25 procedures.During use of the protégé rx self-expanding peripheral stent system, the following complications are reported: bleeding, (with or without transfusion) from puncture channel after pre-existing anticoagulation, fever (differential diagnosis for pneumonia), and hematoma (superficial in area of puncture site) events are reported.All of these events are reported to have been device related and are reported as being not at all concerning.Associated with stent placement an event of thrombosis or occlusion of the stent is reported to have occurred on the 3rd day post-interventional after suspended anticoagulation; resolved without problems by aspiration thrombectomy.The event was deemed device related and reported as being not at all concerning.The protégé gps self-expanding peripheral stent system was used in 20 procedures within the last 12 months for the treatment of lesions that appear to be at high risk for restenosis following pta in the subclavian arteries.Fever (differential diagnosis pneumonia), hematoma (superficial at puncture site), and intraluminal thrombus (without haemodynamic relevance - incidental finding ct thorax scan) events are reported as complications which were deemed device related and reported as being not at all concerning.Associated with stent placement events of dissection or intimal flap (resolved without problems after stent released), thrombosis or occlusion of the stent (asymptomatic after 3 months), and vessel spasm (without any clinical relevance observed at angio) are reported as complications which were deemed device related and reported as being not at all concerning.
|